Roth Capital Starts Global Blood Therapeutics (GBT) at Buy, PT $47

November 1, 2016 8:31 AM EDT
Get Alerts GBT Hot Sheet
Price: $16.40 -4.93%

Rating Summary:
    6 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 27 | New: 28
Trade GBT Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Roth Capital initiated coverage on Global Blood Therapeutics (NASDAQ: GBT) with a Buy rating and a price target of $47.00.

For an analyst ratings summary and ratings history on Global Blood Therapeutics click here. For more ratings news on Global Blood Therapeutics click here.

Shares of Global Blood Therapeutics closed at $17.45 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Hot New Coverage, New Coverage

Related Entities

Roth Capital

Add Your Comment